Kenneth O'Keefe - Dec 2, 2025 Form 4 Insider Report for Jazz Pharmaceuticals plc (JAZZ)

Role
Director
Signature
By: /s/Paz Dizon, as attorney in fact For: Kenneth O'Keefe
Stock symbol
JAZZ
Transactions as of
Dec 2, 2025
Transactions value $
-$104,361
Form type
4
Date filed
12/4/2025, 05:48 PM
Previous filing
Aug 11, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
O'Keefe Kenneth W Director 5TH FL, WATERLOO EXCHANGE, WATERLOO RD, DUBLIN 4, IRELAND By: /s/Paz Dizon, as attorney in fact For: Kenneth O'Keefe 2025-12-04 0001397661

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JAZZ Ordinary Shares Tax liability -$104K -603 -2.28% $173.07 25.8K Dec 2, 2025 Direct F1, F2
holding JAZZ Ordinary Shares 4.45K Dec 2, 2025 by Trust F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Kenneth O'Keefe is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
F2 Reflects the cancellation for no value of 2,258 RSU shares on December 1, 2025.
F3 Shares are held for the benefit of The Kenneth W. O'Keefe Trust U/A/D 2/12/1997, of which the reporting person is both trustee and beneficiary.